Who to call at CytomX Therapeutics, Inc., and when
Fundz watches for the moments CytomX Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day CytomX Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CytomX Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CytomX Therapeutics, Inc.. With Fundz connected, it knows.
CytomX Therapeutics Achieves $5 Million Milestone in Partnership with Regeneron for Bispecific Antibody Development.
Contract Type
partnership
Description
CytomX Therapeutics has announced a preclinical milestone achievement in its strategic collaboration with Regeneron, resulting in a $5 million milestone payment. The partnership aims to develop bispecific antibodies that activate in the tumor microenvironment, enhancing cancer treatment options.
Quick answer
CytomX Therapeutics Achieves $5 Million Milestone in Partnership with Regeneron for Bispecific Antibody Development. (November 17, 2026). CytomX Therapeutics, Inc. is based in San Francisco, California, United States.
- What agreement did CytomX Therapeutics, Inc. announce on November 17, 2026?
- CytomX Therapeutics has announced a preclinical milestone achievement in its strategic collaboration with Regeneron, resulting in a $5 million milestone payment. The partnership aims to develop bispecific antibodies that activate in the tumor microenvironment, enhancing cancer treatment options.
- What does CytomX Therapeutics, Inc. do?
- CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform.
- Where is CytomX Therapeutics, Inc. based?
- CytomX Therapeutics, Inc. is based in San Francisco, California, United States.
- Which similar companies announced agreements around the same time?
- Kernal Biologics (November 17, 2026), Amoéba (November 17, 2026), AcouSort AB (November 17, 2026) and Ainos, Inc. (November 17, 2026) also announced agreements within 45 days of CytomX Therapeutics, Inc.
Source: Fundz verified event record.
Other recent agreements in Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Kernal Bio Establishes Partnership with IFLI to Advance KR-402 for Follicular Lymphoma Treatment. (November 17, 2026)
- Amoéba and Koppert Enhance Biofungicide Partnership for European Orchards. (November 17, 2026)
- AcouSort AB and Edif sign collaboration agreement to explore business opportunities. (November 17, 2026)
- Ainos, Inc. Enters into Equipment Sale Agreement with ASE Technology Holding (November 17, 2026)
- Midwest Transplant Network and InVita Partner to Enhance Organ Donation Efficiency with iTransplant Implementation (November 17, 2026)
- AstraZeneca Pharma India Forms Partnership with Strand Life Sciences for Healthcare Collaboration. (November 17, 2026)
Related People
Agreement Insights
What this usually meansCytomX Therapeutics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.